Sign in

CIK 0001595097 · Non-accelerated filer<br>Smaller reporting company

Corbus Pharmaceuticals Holdings, Inc.

Sign in to watch
Ticker
CRBP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
464348039
Phone
617-963-0103
Business address
500 RIVER RIDGE DRIVE, NORWOOD, MA, 02062
Former names
SAV Acquisition Corp
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,758,438
in 2 filings, $16K under 10b5-1 plans

Net −$1,758,438. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-09-20 Cormorant Asset Management, LP 10% owner Purchase +47,564 $21.47 $1.0M 2,349,231
2024-09-20 Cormorant Asset Management, LP 10% owner Purchase +25,769 $22.23 $573K 2,375,000
2024-08-16 Kung Winston Director Grant or award +5,566 5,566
2024-08-16 Kung Winston Director Grant or award · Stock options (right to buy) +5,566 5,566
2024-06-18 Moran Sean F. Chief Financial Officer Option exercise 10b5-1 +1,958 $30.00 $59K 50,563
2024-06-18 Moran Sean F. Chief Financial Officer Sale 10b5-1 −1,958 $42.12 $82K 48,605
2024-06-18 Moran Sean F. Chief Financial Officer Option exercise · Options to purchase common stock 10b5-1 −1,958 0
2024-06-18 Cohen Yuval Chief Executive Officer Option exercise 10b5-1 +11,667 $30.00 $350K 96,067
2024-06-18 Cohen Yuval Chief Executive Officer Sale 10b5-1 −11,667 $42.24 $493K 84,400
2024-06-18 Cohen Yuval Chief Executive Officer Option exercise 10b5-1 +1,770 $14.10 $25K 86,170
2024-06-18 Cohen Yuval Chief Executive Officer Sale 10b5-1 −1,770 $42.24 $75K 84,400
2024-06-18 Cohen Yuval Chief Executive Officer Option exercise 10b5-1 +2,322 $4.26 $10K 86,722
2024-06-18 Cohen Yuval Chief Executive Officer Sale 10b5-1 −2,322 $42.24 $98K 84,400
2024-06-18 Cohen Yuval Chief Executive Officer Sale 10b5-1 −7,179 $42.24 $303K 77,221
2024-06-18 Cohen Yuval Chief Executive Officer Option exercise · Options to purchase common stock 10b5-1 −11,667 0
2024-06-18 Cohen Yuval Chief Executive Officer Option exercise · Options to purchase common stock 10b5-1 −1,770 31,057
2024-06-18 Cohen Yuval Chief Executive Officer Option exercise · Options to purchase common stock 10b5-1 −2,322 49,739
2024-06-17 Moran Sean F. Chief Financial Officer Option exercise 10b5-1 +6,730 $14.10 $95K 55,335
2024-06-17 Moran Sean F. Chief Financial Officer Sale 10b5-1 −6,730 $46.77 $315K 48,605
2024-06-17 Moran Sean F. Chief Financial Officer Option exercise · Options to purchase common stock 10b5-1 −6,730 11,217

Page 5 of 10 · 200 trades